Asthma results in significant costs in the United States
In an examination of nationally representative data, Sullivan et al estimated the medical expenditures and productivity-related costs associated with asthma. Productivity-related outcome variables included employment, annual wages, missed work days, days spent sick in bed, and activity limitations.
The authors used multivariate regression methods and controlled for the effects of sociodemographic characteristics (such as age, income, and education) as well as other chronic conditions. Results suggest that compared to those without asthma, individuals with asthma were significantly less likely to be employed, spent more days sick in bed, and were significantly more likely to have activity limitations or to be unable to work. Adults with asthma also incurred an additional $1907 ($US 2008) annually and experienced higher medical utilization.
In the United States, $18 billion was spent annually on medical expenditures attributable to adult asthma. The authors conclude that adult asthma is associated with a significant deleterious impact on direct and indirect costs in the United States.
“The Burden of Adult Asthma in the United States: Evidence from the Medical Expenditure Panel Survey” Remarks by Sullivan et al. (JACI February 2011 / Volume 127, No. 2)
The Journal of Allergy and Clinical Immunology (JACI) is the official scientific journal of the AAAAI, and is the most-cited journal in the field of allergy and clinical immunology.